How Semantic Knowledge Graphs Are Transforming Drug Repurposing and Discovery

The process of discovering new drugs is notoriously slow, costly, and complex. Traditional pathways — from target identification to clinical trials — can take more than a decade and billions of dollars. As a result, drug repurposing — finding new therapeutic uses for existing drugs — has emerged as a powerful alternative that can drastically reduce time and cost while improving patient outcomes.

However, even drug repurposing is nontrivial. The biomedical literature and curated databases contain massive amounts of heterogeneous, unstructured data describing relationships between drugs, diseases, genes, proteins, pathways, and clinical outcomes. Extracting actionable insights from this data requires tools that can handle complexity, context, and multi-relational semantics at scale.

This is where semantic knowledge graphs come in — the technology that integrates, organizes, and reasons over rich biomedical knowledge networks to identify promising drug repurposing candidates. Knowledge graphs are a core component of modern semantic content libraries, helping to unlock connections that might otherwise remain hidden. They are at the intersection of graph theory, machine learning, and domain-specific knowledge representation — and they are proving indispensable in accelerating drug discovery.

What Are Semantic Knowledge Graphs?

At their core, knowledge graphs are networks of entities and relationships. Unlike traditional databases that store data in tables, knowledge graphs encode information in a way that explicitly captures semantics — meaning, context, and the nature of relationships. In biomedical domains, these entities might include drugs, diseases, proteins, genes, side effects, biological pathways, and so on. Edges in the graph represent meaningful relationships such as “treats,” “associated with,” “inhibits,” or “expressed by.”

What makes semantic knowledge graphs especially powerful is the ability to integrate information from multiple sources — including curated databases, published research, clinical trial datasets, and expert-annotated ontologies — into a unified structure that machines can traverse and reason over.

This approach contrasts sharply with traditional drug discovery pipelines, which often require manual curation, siloed analyses, and cross-referencing disparate sources of information without a unified semantic framework.

How Knowledge Graphs Enable Drug Prioritization

A landmark example of how semantic knowledge graphs can be applied to drug repurposing comes from research published in Scientific Reports. In this work, researchers constructed a biomedical knowledge graph integrating data from over 200 biological sources. The graph encoded relationships between drugs, diseases, genes, and other biomedical entities, with semantic features extracted as input to a machine learning classifier.

The model was trained using RepoDB, a curated database that labels drug-disease pairs as either approved or failed in clinical trials. By leveraging the semantic properties of the relationships between biomedical concepts, the researchers trained a random forest classifier that achieved a mean area under the ROC curve (AUC) of 92.2% — a strong indication that semantic graph features can effectively distinguish successful drug candidates from unsuccessful ones.

The model was then applied to prioritize preclinical candidates for Autosomal Dominant Polycystic Kidney Disease (ADPKD). Among the top predictions was mozavaptan, a vasopressin V2 receptor antagonist in the same drug class as tolvaptan — the only currently approved treatment for ADPKD. This real-world application demonstrates that knowledge graph-based semantic features can not only prioritize candidates but also reveal relationships that align with biological plausibility and therapeutic class similarities.

Capturing Semantic Relationships for Better Predictions

Semantic knowledge graphs go beyond surface-level connections by capturing indirect semantic pathways between entities. For example, a drug may not be directly linked to a disease, but it may interact with a protein that is part of a pathway implicated in the disease. Semantic paths like these are powerful because they encode more than simple co-occurrence or similarity — they represent biologically meaningful chains of reasoning.

Machine learning models trained on graph-derived features — such as semantic paths, concept co-occurrences, and relational types — are better equipped to infer novel and plausible associations. These associations can then be evaluated experimentally or in silico as repurposing candidates.

Why Semantic Context Matters More Than Ever

The volume of biomedical literature, high-throughput experiments, and clinical data has been growing exponentially. Traditional keyword searches or flat relational databases simply can’t cope with the depth and complexity of this data. Semantic knowledge graphs — which can embed contextual meaning into the relationships between entities — provide a scalable way to link concepts across domains and datasets.

This semantic layer is essential because drug repurposing is fundamentally a discovery of hidden relationships — between drugs, biological mechanisms, and diseases. The ability to traverse a rich semantic graph and quantify relationship strength provides researchers with a structured path to hypotheses that would take human investigators years to uncover manually.

Graph Embeddings and Machine Learning Integration

In addition to traditional semantic features, recent research has shown that combining graph structures with advanced machine learning techniques — such as graph embeddings and neural models — significantly enhances predictive power.

Graph embedding techniques map nodes and relationships into lower-dimensional vector spaces that preserve semantic and structural properties. These embeddings can then be fed into predictive models that rank or classify drug repurposing candidates. Studies show that embeddings can achieve high performance in predicting drug-disease associations, often outperforming baseline heuristics.

One advantage of this approach is scalability — large knowledge graphs with millions of nodes and relationships can be embedded and processed efficiently, enabling broad real-world applications in drug discovery and repositioning.

Beyond Drug Repositioning: Broad Biomedical Applications

Semantic knowledge graphs are not only useful for drug repurposing. They have also been applied to explore combinations of therapies, understand drug synergies, and even predict adverse drug reactions. For example, algorithms that extract semantic predications — subject-predicate-object triples — from biomedical literature can construct graph structures that highlight combination therapies for conditions like cancer.

These broader applications underscore the value of semantic frameworks: they provide researchers with tools to discover new biological insights, accelerate hypothesis generation, and systematically evaluate complex relationships that span across diverse biomedical subfields.

Challenges and Future Directions

Despite their promise, semantic knowledge graphs are not a panacea. Building high-quality graphs requires:

• Standardization of biomedical ontologies and identifiers• Scalable extraction of entities and relationships from unstructured text• Integration of heterogeneous data formats• Robust validation and interpretability of predictions

Emerging research shows that leveraging semantic triples with provenance information can further improve drug efficacy screening and classification tasks — indicating that not all semantic edges are equal, and that relationship metadata matters.

Moreover, combining semantic knowledge graphs with emerging tools — such as transformer-based models and advanced graph neural networks — is yielding models that can both reason over graph structure and interpret complex biomedical semantics.

Why Semantic Knowledge Graphs Matter for Drug Repurposing

Ultimately, drug repurposing is the search for connections that matter — between molecular mechanisms, clinical phenotypes, and therapeutic interventions. Semantic knowledge graphs provide a framework for:

• Integrating vast biomedical knowledge sources• Structuring complex multi-relational data• Guiding machine learning models with biologically meaningful features• Accelerating hypothesis generation and prioritization

By harnessing the power of structured semantic relationships, researchers can accelerate discovery while reducing cost and experimental risk.

In the age of AI-driven research, semantic knowledge graphs aren’t just helpful — they are essential to transforming how biomedical insights are derived and how life-saving therapies are discovered.